| 000 | 01167 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250515220214.0 | ||
| 264 | 0 | _c20100806 | |
| 008 | 201008s 0 0 eng d | ||
| 022 | _a1744-7631 | ||
| 024 | 7 |
_a10.1517/14728221003769903 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSakamoto, Kei | |
| 245 | 0 | 0 |
_aTargeting NF-kappaB for colorectal cancer. _h[electronic resource] |
| 260 |
_bExpert opinion on therapeutic targets _cJun 2010 |
||
| 300 |
_a593-601 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xdrug therapy |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aMaeda, Shin | |
| 773 | 0 |
_tExpert opinion on therapeutic targets _gvol. 14 _gno. 6 _gp. 593-601 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14728221003769903 _zAvailable from publisher's website |
| 999 |
_c19727553 _d19727553 |
||